Becton, Dickinson and Company
One Becton Drive
Franklin Lakes
New Jersey
07417
United States
Tel: 201-847-6800
Fax: 201-847-6475
Website: http://www.bd.com/
866 articles about Becton, Dickinson and Company
-
Becton, Dickinson and Company Announces Webcast Of Annual Meeting Of Shareholders
1/14/2014
-
Becton, Dickinson and Company Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
1/8/2014
-
Becton, Dickinson and Company Announces Collaboration With Pain Management And Palliative Care Infusion Pump Specialists, CME Medical, To Further Support The Growing Therapy Area Of Subcutaneous Infusion
1/8/2014
-
Becton, Dickinson and Company Pays $40 Million For Alverix
1/7/2014
-
Becton, Dickinson and Company To Present At Investor Healthcare Conferences
1/3/2014
-
Biodel Inc. Announces Commercial Supply Agreement With Becton, Dickinson and Company For Liquid Glucagon Rescue Device
12/17/2013
-
Brazil Investigates Becton, Dickinson and Company In Anti-Dumping Probe
12/3/2013
-
Becton, Dickinson and Company To Present At The 25th Annual Piper Jaffray Healthcare Conference
11/27/2013
-
Becton, Dickinson and Company Board Increases Dividend
11/26/2013
-
Becton, Dickinson and Company Joins National Patient Safety Foundation Corporate Council, Furthers Commitment To Safety
11/13/2013
-
Becton, Dickinson and Company's BD Rx Announces FDA Approval of High-Demand Injectable for Pain Management
11/5/2013
-
Becton, Dickinson and Company Announces Results for 2013 Fourth Fiscal Quarter and Full Year; Provides Fiscal 2014 Guidance
11/5/2013
-
Becton, Dickinson and Company Launches BD Helping Build Healthy Communities With Direct Relief and the National Association of Community Health Centers
10/29/2013
-
World Health Organization and Becton, Dickinson and Company Announce New Commitment to Address Maternal and Newborn Mortality
9/30/2013
-
Becton, Dickinson and Company Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
9/30/2013
-
Retractable Technologies, Inc. Awarded $113.51 Million in Lawsuit Against Becton, Dickinson and Company
9/20/2013
-
Retractable Technologies, Inc. Wins a Round Against Becton, Dickinson and Company
9/12/2013
-
FDA Approves Third Drug in Becton, Dickinson and Company's BD Simplist Line
8/30/2013
-
Becton, Dickinson and Company to Present at Investor Healthcare Conferences
8/30/2013
-
Becton, Dickinson and Company ProbeTec™ Trichomonas Vaginalis Q(x) Assay Launches on the BD Viper™ System With XTR™ Technology in the United States
8/27/2013